.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Federal Trade Commission
Healthtrust
US Army
Moodys
Merck
Cantor Fitzgerald
UBS
AstraZeneca

Generated: November 23, 2017

DrugPatentWatch Database Preview

Lactulose - Generic Drug Details

« Back to Dashboard

What are the generic sources for lactulose and what is the scope of lactulose freedom to operate?

Lactulose
is the generic ingredient in fourteen branded drugs marketed by Morton Grove, Fresenius Kabi, Morton Grove Pharms, Teva Pharms, Solvay, Apotex Inc, Cumberland Pharms, Pharm Assoc, Ani Pharms, Paco, Alra, Vistapharm, Actavis Mid Atlantic, Sanofi Aventis Us, Bio-pharm Inc, Hi Tech Pharma, Nostrum Labs, Roxane, West-ward Pharms Int, and Vintage Pharms, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for lactulose. Twenty suppliers are listed for this compound.

Pharmacology for lactulose

Medical Subject Heading (MeSH) Categories for lactulose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms
LACTULOSE
lactulose
SOLUTION;ORAL, RECTAL090426-001Nov 21, 2008AARXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs
ACILAC
lactulose
SOLUTION;ORAL, RECTAL073685-001May 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
CHRONULAC
lactulose
SOLUTION;ORAL017884-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Hi Tech Pharma
LACTULOSE
lactulose
SOLUTION;ORAL, RECTAL074077-001Jul 3, 1995AARXNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
GENERLAC
lactulose
SOLUTION;ORAL, RECTAL071842-001Sep 27, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
LACTULOSE
lactulose
SOLUTION;ORAL, RECTAL076645-001Jul 28, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Morton Grove Pharms
GENERLAC
lactulose
SOLUTION;ORAL, RECTAL074603-001Oct 31, 1996AARXNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
LACTULOSE
lactulose
SOLUTION;ORAL071841-001Sep 22, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs
LAXILOSE
lactulose
SOLUTION;ORAL073686-001May 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms
LACTULOSE
lactulose
SOLUTION;ORAL078430-001Nov 28, 2007AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lactulose

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
CEPHULAC
lactulose
SOLUTION;ORAL, RECTAL017657-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Queensland Health
Express Scripts
Teva
Colorcon
Harvard Business School
Cerilliant
UBS
Mallinckrodt
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot